These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9620916)

  • 1. Effects of topically delivered benzamil and amiloride on nasal potential difference in cystic fibrosis.
    Hofmann T; Stutts MJ; Ziersch A; Rückes C; Weber WM; Knowles MR; Lindemann H; Boucher RC
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1844-9. PubMed ID: 9620916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of topical benzamil and amiloride on nasal potential difference in cystic fibrosis.
    Rodgers HC; Knox AJ
    Eur Respir J; 1999 Sep; 14(3):693-6. PubMed ID: 10543294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosolized amiloride: dose effect on nasal bioelectric properties, pharmacokinetics, and effect on sputum expectoration in patients with cystic fibrosis.
    Hofmann T; Senier I; Bittner P; Hüls G; Schwandt HJ; Lindemann H
    J Aerosol Med; 1997; 10(2):147-58. PubMed ID: 10168532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Benzamil and mucoviscidosis. Primary culture of nasal mucosa as an electrophysiologic in vitro model].
    Blank U; Glanz H; Eistert B; Fryen A; Lindemann H; Hüls G; Clauss W; Weber WM
    HNO; 1996 Apr; 44(4):172-7. PubMed ID: 8655347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease.
    Hirsh AJ; Sabater JR; Zamurs A; Smith RT; Paradiso AM; Hopkins S; Abraham WM; Boucher RC
    J Pharmacol Exp Ther; 2004 Dec; 311(3):929-38. PubMed ID: 15273255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative ion permeability of normal and cystic fibrosis nasal epithelium.
    Knowles M; Gatzy J; Boucher R
    J Clin Invest; 1983 May; 71(5):1410-7. PubMed ID: 6853720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium channel blockers and uridine triphosphate: effects on nasal potential difference in cystic fibrosis mice.
    Ghosal S; Taylor CJ; Colledge WH; Ratcliff R; Evans MJ
    Eur Respir J; 2000 Jan; 15(1):146-50. PubMed ID: 10678637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of airway ion transport assists the diagnosis of cystic fibrosis.
    Middleton PG; House HH
    Pediatr Pulmonol; 2010 Aug; 45(8):789-95. PubMed ID: 20597077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis and non-cystic-fibrosis human nasal epithelium show analogous Na+ absorption and reversible block by phenamil.
    Blank U; Rückes C; Clauss W; Hofmann T; Lindemann H; Münker G; Weber W
    Pflugers Arch; 1997 May; 434(1):19-24. PubMed ID: 9094252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiloride-insensitive nasal potential difference varies with the menstrual cycle in cystic fibrosis.
    Sweezey NB; Smith D; Corey M; Ellis L; Carpenter S; Tullis DE; Durie P; O'Brodovich HM
    Pediatr Pulmonol; 2007 Jun; 42(6):519-24. PubMed ID: 17469152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal apical cell membrane in cystic fibrosis respiratory epithelium. An in vitro electrophysiologic analysis.
    Cotton CU; Stutts MJ; Knowles MR; Gatzy JT; Boucher RC
    J Clin Invest; 1987 Jan; 79(1):80-5. PubMed ID: 3793933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Status of determining the transepithelial potential difference (PD) of the respiratory epithelium in the diagnosis of mucoviscidosis].
    Unal-Maelger OH; Urbanek R
    Monatsschr Kinderheilkd; 1988 Feb; 136(2):76-80. PubMed ID: 2452977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiloride-sensitive Na+ channels in human nasal epithelium are different from classical epithelial Na+ channels.
    Rückes C; Blank U; Möller K; Rieboldt J; Lindemann H; Münker G; Clauss W; Weber WM
    Biochem Biophys Res Commun; 1997 Aug; 237(3):488-91. PubMed ID: 9299389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of nasal membrane potential difference with inhaled amiloride and loperamide in the cystic fibrosis (CF) mouse.
    Ghosal S; Taylor CJ; McGaw J
    Thorax; 1996 Dec; 51(12):1229-32. PubMed ID: 8994520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcellular sodium transport in cultured cystic fibrosis human nasal epithelium.
    Willumsen NJ; Boucher RC
    Am J Physiol; 1991 Aug; 261(2 Pt 1):C332-41. PubMed ID: 1872375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium channel but neither Na(+)-H+ nor Na-glucose symport inhibitors slow neonatal lung water clearance.
    O'Brodovich H; Hannam V; Rafii B
    Am J Respir Cell Mol Biol; 1991 Oct; 5(4):377-84. PubMed ID: 1654956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium.
    Middleton PG; Geddes DM; Alton EW
    Eur Respir J; 1994 Nov; 7(11):2050-6. PubMed ID: 7875281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
    Knowles MR; Church NL; Waltner WE; Yankaskas JR; Gilligan P; King M; Edwards LJ; Helms RW; Boucher RC
    N Engl J Med; 1990 Apr; 322(17):1189-94. PubMed ID: 2157983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways.
    Mall M; Bleich M; Greger R; Schreiber R; Kunzelmann K
    J Clin Invest; 1998 Jul; 102(1):15-21. PubMed ID: 9649552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased nasal potential difference and amiloride sensitivity in neonates with cystic fibrosis.
    Gowen CW; Lawson EE; Gingras-Leatherman J; Gatzy JT; Boucher RC; Knowles MR
    J Pediatr; 1986 Apr; 108(4):517-21. PubMed ID: 3958823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.